|
Academic/Biomedical Research
News & Jobs
|
|
|
|
|
|
|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Company Profiles
Research Store
Research Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
7/28/2011 7:17:10 AM
Atrial fibrillation patients on long-term vitamin K antagonists, such as warfarin, to prevent stroke have an increased risk for coronary calcium, despite their overall low risk for cardiovascular disease, researchers found. The mean coronary artery calcium scores were significantly higher in those taking blood thinners compared with those not taking them (mean score 29, inter-quartile range 0-184, versus 0, IQR 0-40, P<0.001), reported Bob Weijs, MD, from Maastricht University Medical Centre in the Netherlands, and colleagues. The mean calcium scores also rose in conjunction with the duration of blood-thinning therapy, according to the study published online in the European Heart Journal.
|
|
|
|
|
|
|
|
|
|
|